Diabetes Mellitus, Type 1 Clinical Trials

87 recruiting

Diabetes Mellitus, Type 1 Trials at a Glance

88 actively recruiting trials for diabetes mellitus, type 1 are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 33 trials, with the heaviest enrollment activity in Philadelphia, Boston, and Seattle. Lead sponsors running diabetes mellitus, type 1 studies include Novo Nordisk A/S, Eli Lilly and Company, and IRCCS Burlo Garofolo.

Browse diabetes mellitus, type 1 trials by phase

Treatments under study

About Diabetes Mellitus, Type 1 Clinical Trials

Looking for clinical trials for Diabetes Mellitus, Type 1? There are currently 87 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes Mellitus, Type 1 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes Mellitus, Type 1 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 88 trials

Recruiting

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

Diabetes Mellitus, Type 1
Tandem Diabetes Care, Inc.350 enrolled21 locationsNCT07211126
Recruiting
Phase 3

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1
vTv Therapeutics150 enrolled58 locationsNCT06334133
Recruiting
Phase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Diabetes Mellitus, Type 1
Eli Lilly and Company150 enrolled107 locationsNCT07222137
Recruiting
Not Applicable

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Diabetes MellitusDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Senseonics, Inc.80 enrolled1 locationNCT07386340
Recruiting
Phase 3

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled132 locationsNCT07222332
Recruiting

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

Diabetes Mellitus, Type 1
Novo Nordisk A/S245 enrolled37 locationsNCT07160816
Recruiting
Phase 3

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1
Novo Nordisk A/S877 enrolled193 locationsNCT07076199
Recruiting

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Diabetes Mellitus, Type 1
Novo Nordisk A/S630 enrolled80 locationsNCT06807190
Recruiting
Phase 1

Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

Diabetes Mellitus, Type 1
Medical University of South Carolina60 enrolled1 locationNCT04061746
Recruiting
Not Applicable

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1Diabetes Complications
Boston Medical Center140 enrolled2 locationsNCT06236607
Recruiting
Not Applicable

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Diabetes Mellitus, Type 1
Washington University School of Medicine58 enrolled1 locationNCT06503809
Recruiting
Not Applicable

Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM

Diabetes Mellitus, Type 1Immunologic Deficiency Syndromes
Children's Hospital of Fudan University50 enrolled1 locationNCT03835312
Recruiting
Phase 3

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated52 enrolled29 locationsNCT04786262
Recruiting

Genetics Of Autoimmunity In Type I Diabetes

Diabetes MellitusDiabetes Mellitus, Type 1Type1 Diabetes Mellitus+1 more
Medical College of Wisconsin4,000 enrolled1 locationNCT03648918
Recruiting
Not Applicable

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

Diabetes Mellitus, Type 1
University of Alberta20 enrolled1 locationNCT06748963
Recruiting

Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery

Diabetes Mellitus, Type 1Energy Metabolism
Lia Bally40 enrolled1 locationNCT07478211
Recruiting
Not Applicable

Food Insecurity Reduction & Strategy Team

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Food Insecurity
Stanford University160 enrolled1 locationNCT06329375
Recruiting
Phase 1

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Eli Lilly and Company124 enrolled1 locationNCT06945406
Recruiting
Phase 3

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Diabetes Mellitus, Type 1
University of Colorado, Denver60 enrolled2 locationsNCT05819138
Recruiting
Phase 2

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

PreventionDiabetes Mellitus, Type 1Autoimmune Diseases
Diamyd Medical AB16 enrolled1 locationNCT05683990